ELIZABETH WALTON: Open Payments
NPI 1275066839 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 28 payments from 7 companies in 2025. Trend: 2023 $613 · 2024 $407 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $282 |
| PFIZER INC. | 2 | $31 |
| Amgen Inc. | 2 | $29 |
| Novo Nordisk Inc | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| CVRx, Inc. | 1 | $9 |
Products named: LEQVIO, ENTRESTO, VYNDAQEL, REPATHA, Wegovy, WAINUA, UPTRAVI, Barostim Neo System.
Industry payments across TX — which companies pay providers there.
